MYRTLE GROUP PRACTICE — All Prescriptions & Medications — Page 9
Practice Code: N85007 | WIRRAL, CH60 7RN
Showing results 401-450 of 769
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Cyclizine lactate | 85 | 1,315 | £1.3K | +466.7% ▲ |
| Diclofenac sodium | 85 | 4,258 | £471 | +67.4% ▲ |
| Haloperidol | 84 | 2,867 | £6.9K | +76.4% ▲ |
| Valsartan | 83 | 5,572 | £1.2K | +40.9% ▲ |
| Hyoscine hydrobromide | 82 | 5,246 | £845 | +140.1% ▲ |
| Ciprofloxacin | 82 | 1,728 | £173 | +105.6% ▲ |
| 82 | 9,841 | £456 | -70.3% ▼ | |
| Co-amilofruse (Amiloride hydrochloride/frusemide) | 81 | 1,974 | £262 | +132.8% ▲ |
| Other eye tear/lubricant/astringent preparations | 81 | 11.1K | £884 | +640.5% ▲ |
| Doxylamine succinate/pyridoxine hydrochloride | 79 | 3,718 | £5.3K | +615.8% ▲ |
| Cenobamate | 79 | 2,632 | £13.6K | +226.1% ▲ |
| Levodopa/carbidopa/entacapone | 79 | 8,956 | £3.8K | +182.5% ▲ |
| Insulin detemir | 79 | 467 | £3.9K | +0.9% vs avg |
| Canagliflozin | 77 | 3,450 | £4.3K | -46.4% ▼ |
| Triptorelin embonate | 77 | 77 | £30.2K | +673.5% ▲ |
| Powder 6.7 kcal/g energy and protein fortifier (0913141) | 77 | 68.5K | £3.7K | +880.2% ▲ |
| Meloxicam | 77 | 3,189 | £87 | +16.4% ▲ |
| Zonisamide | 76 | 22.2K | £13.3K | +74.2% ▲ |
| 74 | 4,270 | £201 | +36.3% ▲ | |
| Glycerol | 73 | 1,557 | £270 | +108.1% ▲ |
| 73 | 445 | £1.2K | +201.9% ▲ | |
| Tapentadol | 72 | 4,088 | £3.5K | +74.9% ▲ |
| Cocois | 72 | 7,360 | £1.2K | +424.4% ▲ |
| Pivmecillinam hydrochloride | 71 | 1,078 | £567 | +35.2% ▲ |
| 71 | 4,781 | £11.8K | +78.0% ▲ | |
| Naratriptan hydrochloride | 70 | 696 | £134 | +167.7% ▲ |
| Timolol and travoprost | 70 | 395 | £1.4K | +116.6% ▲ |
| Menthol | 70 | 33.0K | £1.2K | +148.6% ▲ |
| Midodrine hydrochloride | 69 | 5,525 | £1.4K | +41.6% ▲ |
| Rasagiline mesilate | 69 | 2,632 | £1.5K | +85.8% ▲ |
| Leflunomide | 69 | 2,430 | £156 | +82.3% ▲ |
| Pyridostigmine bromide | 69 | 15.3K | £1.6K | +303.1% ▲ |
| Exenatide | 68 | 261 | £4.8K | +287.9% ▲ |
| Ready to serve 4.5 - 5 kcal/ml energy (fat) liquid (0913142) | 67 | 166.2K | £5.5K | +497.6% ▲ |
| 67 | 8,760 | £14.0K | +264.0% ▲ | |
| 66 | 695 | £1.4K | +67.8% ▲ | |
| 66 | 1,435 | £814 | +216.8% ▲ | |
| Powder 1.6 kcal/ml milkshake (0913011) | 65 | 1,800 | £989 | -12.8% ▼ |
| 65 | 318 | £808 | +168.3% ▲ | |
| Dipyridamole | 64 | 5,964 | £1.5K | +149.3% ▲ |
| Brimonidine tartrate | 64 | 380 | £225 | +60.3% ▲ |
| 64 | 2,250 | £4.2K | +331.0% ▲ | |
| Glyceryl trinitrate | 63 | 1,890 | £2.4K | +374.2% ▲ |
| Naftidrofuryl oxalate | 63 | 2,268 | £258 | +93.4% ▲ |
| Atomoxetine hydrochloride | 63 | 2,156 | £4.7K | +86.3% ▲ |
| 63 | 63 | £301 | +22.8% ▲ | |
| Buspirone hydrochloride | 62 | 1,946 | £243 | +23.1% ▲ |
| Metoprolol tartrate | 61 | 4,200 | £1.0K | +20.3% ▲ |
| Cinnarizine | 61 | 8,365 | £373 | +30.4% ▲ |
| Febuxostat | 61 | 2,322 | £247 | +63.3% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.